Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Chim, Y. Tong, R. Chiu, T. Lau, T. Leung, L. Chan, C. Oudejans, Chunming Ding, Y. Lo (2005)
Detection of the placental epigenetic signature of the maspin gene in maternal plasma.Proceedings of the National Academy of Sciences of the United States of America, 102 41
(2010)
MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma
S. Founds, J. Dorman, Y. Conley (2008)
Microarray technology applied to the complex disorder of preeclampsia.Journal of obstetric, gynecologic, and neonatal nursing : JOGNN, 37 2
J. Ilekis, U. Reddy, J. Roberts (2007)
Review Article: Preeclampsia—A Pressing Problem: An Executive Summary of a National Institute of Child Health and Human Development WorkshopReproductive Sciences, 14
J. Martin, B. Hamilton, P. Sutton, S. Ventura, F. Menacker, M. Munson (2003)
Births: final data for 2002.National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 52 10
A. Wirth, Z. Benyó, Z. Benyó, M. Lukasova, B. Leutgeb, B. Leutgeb, N. Wettschureck, S. Gorbey, Petra Örsy, B. Horváth, C. Maser‐Gluth, E. Greiner, E. Greiner, B. Lemmer, G. Schütz, J. Gutkind, S. Offermanns (2008)
G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertensionNature Medicine, 14
B. Cox, Parveen Sharma, A. Evangelou, K. Whiteley, V. Ignatchenko, A. Ignatchenko, D. Baczyk, M. Czikk, J. Kingdom, J. Rossant, A. Gramolini, S. Adamson, T. Kislinger (2011)
Translational Analysis of Mouse and Human Placental Protein and mRNA Reveals Distinct Molecular Pathologies in Human Preeclampsia*Molecular & Cellular Proteomics, 10
N. Kanayama, Katsuhiko Takahashi, Toshiki Matsuura, M. Sugimura, Takao Kobayashi, N. Moniwa, Motowo Tomita, K. Nakayama (2002)
Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice.Molecular human reproduction, 8 12
Summary Preeclampsia, characterized by high blood pressure, albuminuria and other systemic disorders, is a serious complication during pregnancy. It has been reported that GNA12 is overexpressed during preeclampsia. In this study, we investigated the potential association between the methylation of the GNA12 promoter and preeclampsia. The methylation level at eight CpG sites of the GNA12 promoter was analyzed by MassARRAY in placenta and peripheral blood DNA samples from 50 preeclampsia patients and 50 normal pregnant women. In the placenta DNA samples, the methylation level at three CpG sites of the GNA12 promoter was significantly lower in the preeclampsia patients than in the controls. The difference was also significant at two of the three CpG sites in the peripheral blood DNA samples. The mRNA expression level of GNA12 in placenta was analyzed by real‐time quantitative PCR in 20 cases and 20 controls. Consistent with the decreased methylation level, the mRNA expression level of GNA12 was higher in preeclampsia patients than in controls. Our results showed that preeclampsia is associated with decreased methylation of the GNA12 promoter, which can be detected in both the placenta and the peripheral blood of the pregnant women.
Annals of Human Genetics – Wiley
Published: Jan 1, 2016
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.